---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005288"
form_type: "8-K"
ticker: "IMDX"
cik: "0001642380"
company_name: "Insight Molecular Diagnostics Inc."
filed_at: "2025-04-17T23:59:59+00:00"
generated_at: "2026-05-23T11:55:41.802710+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Oncocyte terminates Marcum as auditor, engages CBIZ CPAs for FY 2025

## Summary
- Terminated Marcum LLP effective April 11, 2025; engaged CBIZ CPAs P.C. on April 16, 2025 as auditor for FY 2025.
- Change follows CBIZ CPAs' acquisition of Marcum's attest business effective November 1, 2024.
- No disagreements or reportable events occurred during Marcum's tenure through April 11, 2025.
- Marcum's reports for FY 2023 and 2024 were unqualified except for a going-concern note in 2023.

## SEC filing metadata
- accession: 0001641172-25-005288
- form_type: 8-K
- ticker: IMDX
- cik: 0001642380
- company_name: Insight Molecular Diagnostics Inc.
- filed_at: 2025-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642380/000164117225005288/0001641172-25-005288-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642380/000164117225005288/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005288
- JSON: https://secwatch.observer/filing/0001641172-25-005288.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005288.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.